Turkish scientist Prof. Dr. Ali Mazhar Adlı, who conducts studies at the University of Virginia in the U.S., has made two significant discoveries on the treatments of pancreatic and ovarian cancers.

Speaking to state-run Anadolu Agency in Turkey’s southeastern Gaziantep province, where he is going to participate in a scientific meeting organized by SANKO University, Adlı said he had been focusing on how cancer can be destroyed and how alternate drugs against the disease can be developed.

The Turkish scientist had graduated from Middle East Technical University. After receiving his PhD from Harvard University, he moved to University of Virginia where he has been experimenting in his own lab for the past six years.

Read more .. Source : hurriyetdailynews

Disclaimer: This section is a compilation of news, articles, updates and information (“Updates”) related to payments,fintech, banking and other industry. All Updates belong to the source provided after every such Update. FIAKS does not have and in no manner claims to have any intellectual property rights in the content, images, pdf, videos etc. in any of the Updates. This section has been created for knowledge sharing/education purposes for our smart FIAKS communities across the globe. We understand that the fair use of a copyrighted work or work protected under any intellectual property law, including such use by reproduction in copies or by any other means specified under applicable laws, for purposes such as criticism, comment, news reporting, teaching (including multiple copies for classroom use), scholarship, or research, is not an infringement of copyright. This section and our website may contain certain copyrighted or the work otherwise protected under any law that were not specifically authorised to be used by the copyright holder(s) or right holder(s) but which we believe in good faith are protected by the applicable laws and the fair use doctrine for one or more reasons noted above. If you have any specific concerns about this section or our website or our position on the fair use defence, please contact us at [email protected] so we can discuss amicably. Thank you.

Related Post